Risk Stratification of T1 Colorectal Cancer Metastasis to Lymph Nodes: Current Status and Perspective.
Katsuro IchimasaShin-Ei KudoHideyuki MiyachiYuta KouyamaMasashi MisawaYuichi MoriPublished in: Gut and liver (2021)
With the widely spreading population-based screening programs for colorectal cancer and recent improvements in endoscopic diagnosis, the number of endoscopic resections in subjects with T1 colorectal cancer has been increasing. Some reports suggest that endoscopic resection prior to surgical resection of T1 colorectal cancer has no adverse effect on prognosis and contributes to this tendency. The decision on the need for surgical resection as an additional treatment after endoscopic resection of T1 colorectal cancer should be made according to the metastasis risk to lymph nodes based on histopathological findings. Because lymph node metastasis occurs in approximately 10% of patients with T1 colorectal cancer according to current international guidelines, the remaining 90% of patients may be at an increased risk of surgical resection and associated postoperative mortality, with no clinical benefit derived from unnecessary surgical resection. Although a more accurate prediction system for lymph node metastasis is needed to solve this problem, risk stratification for lymph node metastasis remains controversial. In this review, we focus on the current status of risk stratification of T1 colorectal cancer metastasis to lymph nodes and outline future perspectives.
Keyphrases
- lymph node metastasis
- lymph node
- squamous cell carcinoma
- papillary thyroid
- current status
- ultrasound guided
- newly diagnosed
- cardiovascular disease
- type diabetes
- mass spectrometry
- end stage renal disease
- early stage
- high resolution
- cardiovascular events
- risk factors
- adverse drug
- clinical practice
- decision making
- prognostic factors
- electronic health record
- combination therapy